volume 154, issue 9, P811 2019
DOI: 10.1001/jamasurg.2019.1734
View full text
|
|
Share

Abstract: IMPORTANCE Magnetic resonance imaging (MRI) guidance improves the accuracy of prostate biopsy for the detection of clinically significant prostate cancer, but the optimal use of such guidance is not yet clear. OBJECTIVE To determine the cancer detection rate (CDR) of targeting MRI-visible lesions vs systematic prostate sampling in the diagnosis of clinically significant prostate cancer in men who were biopsy naive. DESIGN, SETTING, AND PARTICIPANTS This paired cohort trial, known as the Prospective Assessment …

Expand abstract

Search citation statements

Order By: Relevance

Paper Sections

0
0
0
0
0

Citation Types

4
20
0

Publication Types

Select...

Relationship

0
0

Authors

Journals